<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="translate">
<roleset id="translate.01" name="molecular event of producing genetic product called protein
" wordnet="10">
<roles>
  <role n="0" descr="resultant product 			// protein //
"/>
  <role n="1" descr="source 					// mRNA, transcript // 
"/>
  <role n="2" descr="location as tissue, cell, vitro
"/>
</roles>
<example src="MEDLINE" no="*1">
<text>
Alternative splicing of exon 4 results in a transcript which would be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein. 

</text>
       <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains
</arg>
       <arg n="1">a transcript
</arg>
       <arg n="2">-
</arg>
<fdg>
1	Alternative	alternative	attr:&gt;2	@A&gt; %&gt;N N NOM SG	@A&gt; %&gt;N A ABS
2	splicing	splicing		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@PCOMPL-S %NH N NOM SG
3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
4	exon	exon	pcomp:&gt;3	@&lt;P %NH N NOM SG
5	4	4	qn:&gt;6	@QN&gt; %&gt;N NUM CARD
6	results	result		@NH %NH N NOM PL	@SUBJ %NH N NOM PL
7	in	in	mod:&gt;6	@&lt;NOM %N&lt; PREP
8	a	a	det:&gt;9	@DN&gt; %&gt;N DET SG
9	transcript	transcript	pcomp:&gt;7	@&lt;P %NH N NOM SG
10	which	which	subj:&gt;11	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
11	would	would	v-ch:&gt;12	@+FAUXV %AUX V AUXMOD
12	be	be	v-ch:&gt;13	@-FAUXV %AUX V INF
13	translated	translate	mod:&gt;9	@-FMAINV %VP EN
14	into	into	goa:&gt;13	@ADVL %EH PREP
15	a	a	det:&gt;18	@DN&gt; %&gt;N DET SG
16	C-terminal	c-terminal	attr:&gt;17	@A&gt; %&gt;N A ABS
17	truncated	truncated	attr:&gt;18	@A&gt; %&gt;N A ABS
18	protein	protein	pcomp:&gt;14	@&lt;P %NH N NOM SG
19	containing	contain	mod:&gt;18	@-FMAINV %VA ING
20	the	the	det:&gt;21	@DN&gt; %&gt;N DET
21	first	first		@ADVL %EH NUM ORD
22	,	,
23	second	second		@A&gt; %&gt;N NUM ORD	@PCOMPL-S %NH NUM ORD	@SUBJ %NH NUM ORD	@OBJ %NH NUM ORD	

@ADVL %EH NUM ORD	@&lt;P %NH NUM ORD	@&lt;NOM %N&lt; NUM ORD
24	and	and		@CC %CC CC
25	third	third	attr:&gt;26	@A&gt; %&gt;N NUM ORD
26	transmembrane	transmembrane	attr:&gt;27	@A&gt; %&gt;N &lt;?&gt; N NOM SG
27	domains	domain		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL	@APP %NH N 

NOM PL	@&lt;P %NH N NOM PL
28	,	,
29	while	while	tmp:&gt;38	@ADVL %EH ADV WH
30	the	the	det:&gt;31	@DN&gt; %&gt;N DET
31	splicing	splicing	subj:&gt;37	@SUBJ %NH A ABS
32	out of	out of	mod:&gt;31	@&lt;NOM %N&lt; PREP
33	exons	exon	pcomp:&gt;32	@&lt;P %NH &lt;?&gt; N NOM PL
34	3	3	mod:&gt;33	@&lt;NOM %N&lt; NUM CARD
35	and	and	cc:&gt;34	@CC %CC CC
36	4	4	cc:&gt;34	@&lt;NOM %N&lt; NUM CARD
37	would	would	v-ch:&gt;38	@+FAUXV %AUX V AUXMOD
38	produce	produce	tmp:&gt;19	@-FMAINV %VA V INF
39	a	a	det:&gt;40	@DN&gt; %&gt;N DET SG
40	protein	protein	obj:&gt;38	@OBJ %NH N NOM SG
41	with	with	ins:&gt;38	@ADVL %EH PREP
42	five	five	qn:&gt;44	@QN&gt; %&gt;N NUM CARD
43	membrane-spanning	membrane-spanning	attr:&gt;44	@A&gt; %&gt;N &lt;?&gt; A ABS
44	domains	domain	pcomp:&gt;41	@&lt;P %NH N NOM PL
45	but	but		@CC %CC CC
46	lacking	lack		@&lt;P-FMAINV %VA ING	@-FMAINV %VA ING
47	the	the	det:&gt;51	@DN&gt; %&gt;N DET
48	third	third	cc:&gt;50	@A&gt; %&gt;N NUM ORD
49	and	and	cc:&gt;50	@CC %CC CC
50	fourth	fourth	attr:&gt;51	@A&gt; %&gt;N NUM ORD
51	domains	domain		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL
52	present	present		@-FMAINV %VA V INF	@&lt;P-FMAINV %VA V INF	@PCOMPL-S %NH A ABS	@&lt;NOM %N&lt; A 

ABS
53	in	in		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
54	the	the	det:&gt;56	@DN&gt; %&gt;N DET
55	ET-AR	et-ar	attr:&gt;56	@A&gt; %&gt;N N NOM SG
56	protein	protein	pcomp:&gt;53	@&lt;P %NH N NOM SG
57	.     .
</fdg>
</example>
<example src="EMBO" no="1">
<text>
Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 were translated in vitro and partially purified on heparin-agarose.

</text>
       <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1
</arg>
       <arg n="1">-
</arg>
       <arg n="2">vitro
</arg>
<fdg>
1	Stat1	stat1	cc:&gt;4	@SUBJ %NH N NOM SG
2	,	,
3	Stat1	stat1	attr:&gt;4	@A&gt; %&gt;N N NOM SG
4	Y701F	y701f	cc:&gt;7	@SUBJ %NH NUM CARD
5	,	,
6	Stat1	stat1	attr:&gt;7	@A&gt; %&gt;N N NOM SG
7	N135	n135	cc:&gt;10	@SUBJ %NH N NOM SG
8	,	,
9	Stat1	stat1	attr:&gt;10	@A&gt; %&gt;N N NOM SG
10	N200	n200	cc:&gt;12	@SUBJ %NH N NOM SG
11	and	and	cc:&gt;12	@CC %CC CC
12	Stat5/1	stat5/1	subj:&gt;13	@SUBJ %NH &lt;?&gt; NUM CARD
13	were	be	v-ch:&gt;14	@+FAUXV %AUX V PAST PL
14	translated	translate	main:&gt;0	@-FMAINV %VP EN
15	in vitro	in vitro		@ADVL %EH ADV	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
16	and	and	cc:&gt;14	@CC %CC CC
17	partially	partially	man:&gt;18	@ADVL %EH ADV
18	purified	purify	cc:&gt;14	@-FMAINV %VP EN
19	on	on	ha:&gt;18	@ADVL %EH PREP
20	heparin	heparin	pcomp:&gt;19	@&lt;P %NH &lt;?&gt; N NOM SG
21	-	-
22	agarose	agarose	obj:&gt;18	@OBJ %NH &lt;?&gt; N NOM SG
23	.     .
</fdg>
</example>
<example src="EMBO" no="2">
<text>
Stat1 Y701F translated in vitro can also dimerize on the LMP2 GAS.

</text>
       <arg n="0">Stat1 Y701F
</arg>
       <arg n="1">-
</arg>
       <arg n="2">vitro
</arg>
<fdg>
1	Stat1	stat1		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@A&gt; %&gt;N N NOM SG
2	Y701F	y701f		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
3	translated	translate		@-FMAINV %VP EN
4	in vitro	in vitro	ha:&gt;3	@ADVL %EH ADV
5	can	can	v-ch:&gt;7	@+FAUXV %AUX V AUXMOD
6	also	also	meta:&gt;7	@ADVL %EH ADV
7	dimerize	dimerize		@-FMAINV %VA V INF
8	on	on	ha:&gt;7	@ADVL %EH PREP
9	the	the	det:&gt;11	@DN&gt; %&gt;N DET
10	LMP2	lmp2	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	GAS	gas	pcomp:&gt;8	@&lt;P %NH N NOM SG
12	.     .
</fdg>
</example>
<example src="EMBO" no="3">
<text>
In vitro translation and partial purification of fStat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 were translated in vitro using the T7-based coupled transcription-translation kit (Promega) as per the manufacturer fs instructions.

</text>
       <arg n="0">Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1
</arg>
       <arg n="1">-
</arg>
       <arg n="2">vitro
</arg>
<fdg>

1	In vitro	in vitro	attr:&gt;2	@A&gt; %&gt;N A ABS
2	translation	translation	cc:&gt;5	@SUBJ %NH N NOM SG
3	and	and	cc:&gt;5	@CC %CC CC
4	partial	partial	attr:&gt;5	@A&gt; %&gt;N A ABS
5	purification	purification	subj:&gt;20	@SUBJ %NH N NOM SG
6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
7	Stat1	stat1	attr:&gt;8	@A&gt; %&gt;N N NOM SG
8	Stat1	stat1	pcomp:&gt;6	@&lt;P %NH N NOM SG
9	,	,
10	Stat1	stat1	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	Y701F	y701f	cc:&gt;8	@&lt;P %NH NUM CARD
12	,	,
13	Stat1	stat1	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	N135	n135	cc:&gt;11	@&lt;P %NH N NOM SG
15	,	,
16	Stat1	stat1	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	N200	n200	cc:&gt;14	@&lt;P %NH N NOM SG
18	and	and	cc:&gt;17	@CC %CC CC
19	Stat5/1	stat5/1	cc:&gt;17	@&lt;P %NH &lt;?&gt; NUM CARD
20	were	be	v-ch:&gt;21	@+FAUXV %AUX V PAST PL
21	translated	translate	main:&gt;0	@-FMAINV %VP EN
22	in vitro	in vitro		@ADVL %EH ADV	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
23	using	use		@-FMAINV %VA ING
24	the	the	det:&gt;28	@DN&gt; %&gt;N DET
25	T7-based	t7-based	attr:&gt;26	@A&gt; %&gt;N &lt;?&gt; A ABS
26	coupled	coupled	attr:&gt;27	@A&gt; %&gt;N A ABS
27	transcription-translation	transcription-translation	attr:&gt;28	@A&gt; %&gt;N &lt;?&gt; N NOM SG
28	kit	kit	obj:&gt;23	@OBJ %NH N NOM SG
29	(	(
30	Promega	promega	mod:&gt;28	@NH %NH &lt;?&gt; N NOM SG
31	)	)
32	as per	as per	ha:&gt;23	@ADVL %EH PREP
33	the	the	det:&gt;36	@DN&gt; %&gt;N DET
34	manufacturer	manufacturer	attr:&gt;35	@A&gt; %&gt;N N NOM SG
35	fs	f	attr:&gt;36	@A&gt; %&gt;N &lt;?&gt; N NOM PL
36	instructions	instruction	pcomp:&gt;32	@&lt;P %NH N NOM PL
37	.     .
</fdg>
</example>
<example src="EMBO" no="4">
<text>
We also report the first definitive incorporation of Sec into a selenoprotein translated in reticulocyte lysates.

</text>
       <arg n="0">a selenoprotein
</arg>
       <arg n="1">-
</arg>
       <arg n="2">reticulocyte lysates
</arg>
<fdg>
1	We	we	subj:&gt;3	@SUBJ %NH PRON PERS NOM PL1
2	also	also	meta:&gt;3	@ADVL %EH ADV
3	report	report	main:&gt;0	@+FMAINV %VA V PRES
4	the	the	det:&gt;7	@DN&gt; %&gt;N DET
5	first	first	attr:&gt;6	@A&gt; %&gt;N NUM ORD
6	definitive	definitive	attr:&gt;7	@A&gt; %&gt;N A ABS
7	incorporation	incorporation	obj:&gt;3	@OBJ %NH N NOM SG
8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
9	Sec	sec	pcomp:&gt;8	@&lt;P %NH ABBR NOM SG
10	into	into	goa:&gt;3	@ADVL %EH PREP
11	a	a	det:&gt;12	@DN&gt; %&gt;N DET SG
12	selenoprotein	selenoprotein	pcomp:&gt;10	@&lt;P %NH &lt;?&gt; N NOM SG
13	translated	translate	mod:&gt;12	@-FMAINV %VP EN
14	in	in	ha:&gt;13	@ADVL %EH PREP
15	reticulocyte	reticulocyte	attr:&gt;16	@A&gt; %&gt;N &lt;?&gt; N NOM SG
16	lysates	lysat*	pcomp:&gt;14	@&lt;P %NH &lt;?&gt; N NOM
17	.     .
</fdg>
</example>
<example src="EMBO" no="*5">
<text>
This mutant was translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.

</text>
       <arg n="0">This mutant
</arg>
       <arg n="1">-
</arg>
       <arg n="2">-
</arg>
<fdg>
1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
2	mutant	mutant	subj:&gt;3	@SUBJ %NH N NOM SG
3	was	be	v-ch:&gt;4	@+FAUXV %AUX V PAST
4	translated	translate		@-FMAINV %VP EN
5	in	in	man:&gt;4	@ADVL %EH PREP
6	the	the	det:&gt;7	@DN&gt; %&gt;N DET
7	presence	presence	pcomp:&gt;5	@&lt;P %NH N NOM SG
8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
9	C-terminal	c-terminal	attr:&gt;10	@A&gt; %&gt;N A ABS
10	SBP2	sbp2	pcomp:&gt;8	@&lt;P %NH N NOM SG
11	,	,
12	and	and		@CC %CC CC
13	as	as	pm:&gt;14	@CS %CS CS
14	shown	show		@-FMAINV %VP EN
15	in	in	ha:&gt;14	@ADVL %EH PREP
16	Figure	figure	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	6C	6c	qn:&gt;18	@QN&gt; %&gt;N NUM CARD
18	no	no	det:&gt;19	@DN&gt; %&gt;N DET
19	readthrough	readthrough	pcomp:&gt;15	@&lt;P %NH &lt;?&gt; N NOM SG
20	is	be		@+FMAINV %VA V PRES SG3
21	detectable	detectable	comp:&gt;20	@PCOMPL-S %NH A ABS
22	when	when	tmp:&gt;27	@ADVL %EH ADV WH
23	the	the	det:&gt;25	@DN&gt; %&gt;N DET
24	AUGA	auga	attr:&gt;25	@A&gt; %&gt;N N NOM SG
25	element	element	subj:&gt;26	@SUBJ %NH N NOM SG
26	is	be	v-ch:&gt;27	@+FAUXV %AUX V PRES SG3
27	deleted	delete	tmp:&gt;20	@-FMAINV %VP EN
28	,	,
29	indicating	indicate	man:&gt;27	@-FMAINV %VA ING
30	that	that	pm:&gt;34	@CS %CS CS
31	the	the	det:&gt;33	@DN&gt; %&gt;N DET
32	stimulatory	stimulatory	attr:&gt;33	@A&gt; %&gt;N A ABS
33	effect	effect	subj:&gt;34	@SUBJ %NH N NOM SG
34	is	be	obj:&gt;29	@+FMAINV %VA V PRES SG3
35	entirely	entirely	ad:&gt;36	@AD-A&gt; %E&gt; ADV
36	3	3	qn:&gt;38	@QN&gt; %&gt;N NUM CARD
37	&apos;	&apos;
38	UTR	utr	comp:&gt;34	@PCOMPL-S %NH N NOM SG
39	dependent	dependent	mod:&gt;38	@&lt;NOM %N&lt; A ABS
40	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
